Preoperative markers for the prediction of high-risk features in endometrial cancer

Table 1 Baseline clinicopathological characteristics, n (%)

Characteristics	n = 128
Age (yr), mean ± SD	57.4 ± 10.9
BMI (kg/m2), mean ± SD	27.7 ± 7.5
Obesity (BMI > 30 kg/m2)	37 (28.9)
Parity
Nulliparous	61 (47.7)
Multiparous	67 (52.3)
Menopausal status
Premenopause	39 (30.5)
Postmenopause	89 (69.5)
Coexisting medical diseases1	80 (62.5)
Pre-existing breast cancer	12 (9.4)
Coexisting benign gynecologic diseases2	72 (56.3)
Surgical stage of disease
Stage I	86 (67.2)
Stage II	15 (11.7)
Stage III	19 (14.8)
Stage IV	8 (6.3)
Histologic grade
Grade 1 endometrioid carcinoma	71 (55.5)
Grade 2 endometrioid carcinoma	23 (18.0)
Grade 3 endometrioid carcinoma	31 (24.2)
Uterine papillary serous carcinoma	2 (1.6)
Carcinosarcoma	1 (0.8)

¹Medical diseases included hypertension, dyslipidemia, heart disease, thyroid disease, and connective tissue diseases;

²Benign gynecologic diseases such as leiomyoma, adenomyosis, or pelvic and ovarian endometriosis. BMI: Body mass index.